首页 › 基金 › Jones Hill Capital LP › LXEO

Jones Hill Capital LP 对 LXEO 的持仓历史

LEXEO THERAPEUTICS INC · 医疗保健

Jones Hill Capital LP 在 Q3 2026 的 13F 申报中披露持有 LXEO(LEXEO THERAPEUTICS INC)593,737 股,市值约 US$2.0M,约占其申报组合的 0.34%,在其申报持仓中市值排名第 30 位。 Jones Hill Capital LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)593.74K 股
申报持仓市值$2.01M
组合权重0.34%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Jones Hill Capital LP 对 LXEO 的持仓演变

Jones Hill Capital LP 于 Q3 2026 首次披露 LXEO 持仓:593,737 股(约 US$2.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 593.74K $2.01M 新进

关于 LXEO 与 13F 数据

LXEO(LEXEO THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 LXEO,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$29.7M), Affinity Asset Advisors, LLC (US$27.0M), Frazier Life Sciences Management, L.P. (US$22.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 LXEO 的基金

查看 LXEO 的全部基金持有人 →

常见问题

How long has Jones Hill Capital LP held LXEO?

Jones Hill Capital LP has disclosed LXEO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Jones Hill Capital LP's current position in LXEO?

As of Q3 2026, Jones Hill Capital LP holds 593.74K shares of LXEO (LEXEO THERAPEUTICS INC), valued at $2.01M, representing 0.34% of its reported portfolio and ranking #30.

Has Jones Hill Capital LP been buying or selling LXEO?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in LXEO.

Which other funds hold LXEO?

Other major institutional holders of LXEO include MONTANOVA CAPITAL, LLC, Affinity Asset Advisors, LLC, Frazier Life Sciences Management, L.P., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.